These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35753064)

  • 1. Global trends and the impact of chronic hepatitis B and C on disability-adjusted life years.
    Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
    Liver Int; 2022 Oct; 42(10):2145-2153. PubMed ID: 35753064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019.
    GBD 2019 Europe Hepatitis B & C Collaborators
    Lancet Public Health; 2023 Sep; 8(9):e701-e716. PubMed ID: 37633679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.
    Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
    J Viral Hepat; 2022 May; 29(5):352-365. PubMed ID: 35274406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.
    Degenhardt L; Charlson F; Stanaway J; Larney S; Alexander LT; Hickman M; Cowie B; Hall WD; Strang J; Whiteford H; Vos T
    Lancet Infect Dis; 2016 Dec; 16(12):1385-1398. PubMed ID: 27665254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of chronic viral hepatitis B and C in Minnesota Somalis contributes to rising hepatocellular carcinoma incidence.
    Mohamed EA; Giama NH; Abdalla AO; Shaleh HM; Oseini AM; Ali HA; Ahmed F; Taha W; Ahmed Mohammed H; Cvinar J; Waaeys IA; Ali H; Allotey LK; Ali AO; Mohamed SA; Harmsen WS; Ahmmad EM; Bajwa NA; Afgarshe MD; Shire AM; Balls-Berry JE; Roberts LR
    World J Gastroenterol; 2022 Sep; 28(35):5217-5229. PubMed ID: 36188718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C and hepatitis B-related mortality in Spain.
    García-Fulgueiras A; García-Pina R; Morant C; García-Ortuzar V; Génova R; Alvarez E
    Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):895-901. PubMed ID: 19357523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030.
    Meijerink H; White RA; Løvlie A; de Blasio BF; Dalgard O; Amundsen EJ; Melum E; Kløvstad H
    BMC Infect Dis; 2017 Aug; 17(1):541. PubMed ID: 28774261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of disease related to hepatitis C and hepatitis B in Spain: a methodological challenge of an unfolding health problem.
    García-Fulgueiras A; García-Pina R; Morant C; de Larrea-Baz NF; Alvarez E
    J Viral Hepat; 2011 Oct; 18(10):e453-60. PubMed ID: 21914063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.
    Paik JM; Golabi P; Younossi Y; Mishra A; Younossi ZM
    Hepatology; 2020 Nov; 72(5):1605-1616. PubMed ID: 32043613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global mortality of chronic liver diseases attributable to Hepatitis B virus and Hepatitis C virus infections from 1990 to 2019 and projections to 2030.
    Ou TY; Huy LD; Mayne J; Shih CL; Mai Xuan H; Thi Hong Nguyen N; Nguyen Hoai L; Thi My Bui L; Chang YM; Abdi AA; Hsu SC; Lin HJ; Huang CC
    J Infect Public Health; 2024 Jul; 17(7):102443. PubMed ID: 38838606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of Hepatitis C in Iran Between 1990 and 2010: findings from the Global Burden of Disease Study 2010.
    Mohaghegh Shalmani H; Noori A; Shokoohi M; Khajavi A; Darvishi M; Delavari A; Jamshidi HR; Naderimagham S
    Arch Iran Med; 2015 Aug; 18(8):508-14. PubMed ID: 26265519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing relative roles of hepatitis B and C viruses in the aetiology of hepatocellular carcinoma in Greece. Epidemiological and clinical observations.
    Raptis I; Koskinas J; Emmanouil T; Hadziyannis S
    J Viral Hepat; 2003 Nov; 10(6):450-4. PubMed ID: 14633179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Hepatitis B Collaborators
    Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):796-829. PubMed ID: 35738290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing global epidemiology of chronic hepatitis C virus-related outcomes from 2010 to 2019: cirrhosis is the growing burden of hepatitis C virus-related disease.
    Pham YT; Huang DQ; Zhang Z; Ng CH; Tan DJH; Nguyen HC; Nguyen TC; Behari J; Yuan JM; Luu HN
    Eur J Cancer Prev; 2024 Nov; 33(6):512-524. PubMed ID: 38568179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of Chronic Viral Hepatitis and Liver Cirrhosis in Brazil - the Brazilian Global Burden of Disease Study.
    de Carvalho JR; Villela-Nogueira CA; Perez RM; Portugal FB; Flor LS; Campos MR; Schramm JMA
    Ann Hepatol; 2017 November-December,; 16(6):893-900. PubMed ID: 29055917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.
    Hernandez BY; Zhu X; Kwee S; Chan OT; Tsai N; Okimoto G; Horio D; McGlynn KA; Altekruse S; Wong LL
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2016-23. PubMed ID: 23983238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographical disparities in hepatitis b virus related hepatocellular carcinoma mortality rates worldwide from 1990 to 2019.
    Zhang NS; Wong RJ
    Medicine (Baltimore); 2023 May; 102(21):e33666. PubMed ID: 37233436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.
    Makarova M; Krettek A; Valkov MY; Grjibovski AM
    Int J Circumpolar Health; 2013; 72():20282. PubMed ID: 23687637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the 2008 economic crisis on the burden of hepatitis B and C diseases in Southern European countries.
    Palladino C; Ramis R; Ezeonwumelu IJ; Biondi A; Carreras G; Fischer F; Gallus S; Golinelli D; Gorini G; Hassan S; Kabir Z; Koyanagi A; Lazarus JV; Mentis AA; Meretoja TJ; Mokdad AH; Monasta L; Mulita F; Postma MJ; Tabarés-Seisdedos R; Thiyagarajan A; Taveira N; Briz V;
    BMC Public Health; 2024 Jun; 24(1):1642. PubMed ID: 38902642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.